Search

everythinglearnresearchcommunity

for

Search:↓

Compound 4 is a promising treatment for hair loss with low toxicity.

Infrared light can trigger drug release from gold nanoparticle carriers in hair follicles.

Nanocarriers like liposomes and cyclodextrins improve how angiotensin-(1-7) is delivered in the body.

Most patients experienced mild to moderate skin problems during a trial for a desmoid tumor treatment.

The method accurately measures finasteride in skin after using special carriers.

Horizant has risks like other seizure drugs, Johnson & Johnson misled about Risperdal, and Quanterix found a possible link between brain oxygen loss and Alzheimer's markers.

Blocking a certain signal in the gp130 receptor can improve tissue healing and lessen osteoarthritis symptoms.

Astilbin can potentially calm overactive immune responses, like in Type 1 Diabetes, by suppressing certain cell activities and reducing inflammation.

Changing protein kinase levels in pituitary cells affects calcium flow and beta-endorphin release.

UHP-sCESr is as effective as HESr for treating BPH symptoms.

Keratin 17 is modified by RSK1 in response to growth and stress, affecting skin growth and stress response.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

SHPro® improved urinary symptoms and erectile function in men and is safe.

PSA levels are higher in women with PCOS, but FAI is a more accurate marker for diagnosis.

NXC736 significantly reduced hair loss in mice with alopecia areata.

The technology can help diagnose and subtype autoimmune diseases by identifying specific autoantibodies.

Phenobarbitone can cause severe and sometimes fatal skin reactions.

Microneedles can precisely deliver cancer treatments with fewer side effects.

A new device, IVL-PPF Microsphere®, was created to deliver a hair loss drug for up to 3 months with one injection, potentially replacing daily pills.

Compounds from Pterocarpus indicus may help treat benign prostatic hyperplasia by stopping cell growth.

DPP may help hair regrowth by improving blood vessel function under stress.

Always consider xanthomatous hypophysitis before deciding on pituitary surgery.

PBX1 reduces aging and cell death in stem cells by boosting SIRT1 and lowering PARP1.

Inhibiting PDE8A may help treat hair loss by boosting fat cell growth and hair regeneration.

The method reliably measures finasteride in human plasma.

11α-Hydroxyprogesterone is changed into different substances by certain enzymes and may play a role in prostate cancer.

Injections improve hair growth, density, and thickness in women safely.